Safety and efficacy of cisplatin plus 5-FU and cetuximab in HPV-positive and HPV-negative recurrent and/or metastatic squamous cell carcinoma of the head and neck (r/m SCCHN): analysis of the phase III extreme trial
A. Psyrri
Safety and efficacy of cisplatin plus 5-FU and cetuximab in HPV-positive and HPV-negative recurrent and/or metastatic squamous cell carcinoma of the head and neck (r/m SCCHN): analysis of the phase III extreme trial
A. Psyrri